Our results indicated that F13A1 is upregulated in M2 Mø from AKI and CKD patients (Figures 3A,B) and the main source of F13A1 expression in human kidney patients is Mø (Figure 3C). This evidence concerns the gene F13A1 and chronic kidney disease.